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As it can be seen, the developed treatment planning system 
is able to clearly show the variations of isodose levels at the 
site of tumor bed. Therefore, treatment team can precisely 
determine the interested isodose level for the dose 
prescription.The results of in vivo dosimetry at the surface of 
tumor bed showed there is no meaningful difference between 
the measured and expected dose at the surface of tumor bed 
(P-value=0.92). 
 
Conclusion: The feasibility of intraoperative imaging and 
development of a postoperative image based treatment 
planning system during breast cancer IOERT was investigated 
in this study. The results of in vivo dosimetry confirm the 
validity of the developed treatment planning system for 
clinical applications. 
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Purpose or Objective: To compare the differences between 
average doses cumulated in the marrow of iliac plates (PBM), 
obtained for five different radiotherapy strategies of cervical 
and endometrial cancer. 
 
Material and Methods: A total of 150 treatment plans were 
calculated retrospectively for 30 patients with cervical and 
endometrial cancer.  
For each case, 3 different dose delivery techniques were 
used. It were respectively: (i) 4-field, X15MV, 3DCRT; (ii) 7-
field, X6MV, IMRT; and (iii) 2-arc, X6MV, VMAT. Two 
strategies were used during preparation of the IMRT and 
VMAT plans. The first take into account (+) PBM during 
optimization of the dose distribution and the second, do not 
take it into account (-).  
All plans were normalized on the median dose in PTV. The 
same calculation algorithm (AAA) was used for calculation of 
the dose for each of plan. The total dose was 50.4 Gy (1.8 Gy 
in 28 fractions).  
Average doses cumulated in PTV, PBM, bladder, rectum, 
bowels and femoral heads obtained from the evaluated plans 
were compared. In addition, the doses accumulated in PBM 
were analyzed in the light of the volume of PTV and/or PBM.  
The statistical analysis were performed by Friedman ANOVA 
with Nemenyi's procedures used as post-hoc tests. In order to 
find the relationship between doses in PBM and volume of 
PTV and/or PBM, the Spearman correlation was used. All 
tests were performed on the significance level equal to 0.05. 
 
Results: Table 1 shows the result of the comparison of the 
average dose in the light of the generated plans. 
 
 
 
The average dose in PTV for evaluated plans was similar. The 
worst doses in organs at risk were obtained for 3DCRT. Using 
the PBM during optimization of IMRT and VMAT reduces the 
average dose in PBM without increasing the doses in bladder, 
rectum and bowels. Differences between doses in PBM for 
IMRT and VMAT plans, where PBM was used during 
optimization, were not statistically significant. The 
correlation between mean dose in PBM and the volume ratio 
of PBM and PTV was found for each technique (Figure 1). 
 
 
 
Conclusion: Using the PBM during optimization of the IMRT 
and VMAT plans effectively reduces the dose in PBM without 
increasing the dose in bladder, rectum and bowels. The 
doses, obtained in PBM for IMRT and VMAT are not 
statistically different. Decreasing the PBM volume in relation 
to PTV increases the mean dose in PBM. 
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Purpose or Objective: The introduction of lung stereotactic 
body radiation therapy (SBRT) requires images that allow a 
more precise delineation of the tumor and its movement. The 
free breathing CT does not contain information on the 
variable electron density over time. The objective of this 
study is to analyze the CT mode that provides the best 
estimation of the tumor movement and the most appropriate 
image set for the calculation of the dose distribution image. 
 
Material and Methods: 10 patients were retrospectively 
investigated. For each patient, a retrospective 4DCT was 
acquired using a Brilliance 16-slice scanner. From the 4DCT 
study, 10 respiratory phases, an average CT and a maximum 
intensity projection (MIP) were reconstructed. The gross 
tumor volumes (GTV) were delineated in each image set of 
the 4DCT using a MIM® 6.4 software. Three internal target 
volumes (ITV) were obtained, one from the union of GTVs 
delineated in each phase, another from the average CT and 
the last from the MIP reconstruction. Special care was taken 
with the window level selection when contouring. The size of 
the three ITVs was compared. The planning target volume 
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(PTV) was created adding a margin of 5 mm to the ITV .The 
dose distribution was optimized on the average CT 
prescribing a dose of 20 Gy per fraction delivering a total 
dose of 60 Gy to the PTV. The plans were calculated in a 
Phillips Pinnacle 9.10 planning system using conformal 3DRT 
and heterogeneity correction. The parameters obtained in 
the average CT optimized plan, were copied to the different 
image sets with identical monitor units to analyze the 
differences. 
 
Results: The average GTV volume was 1.6 ± 1.1 cc. The ITV 
size is twice the lesion size in most of the cases except in 
those with higher breathing amplitude. The ITVs outlined in 
the average CT were smaller than those outlined in the 4DCT 
ranging from 0.1 cc, where there hardly was lesion 
movement, to 0.6 cc. The differences between the volumes 
were usually found in the cranio-caudal direction due to the 
higher movement of the lesion in this direction. The ITVs 
outlined in the MIP CT were equivalent to the 4DCT except in 
the cases where there was a higher density organ in the 
vicinity of the tumor. Respect to dose distribution, the dose 
of the organs at risk shows no significant differences in the 
different image sets. The V100 of the ITV presents significant 
variations up to 15% due to the variation in electron densities 
depending on the CT mode chosen. The V100 of the GTV 
calculated in each phase is greater than 97%. 
 
 
 
Conclusion: We recommend using the ten phases of the 4DCT 
study for proper delineation of ITV. If the institution does not 
have the technology the CT average (low pitch CT) could be 
used selecting the appropriate window level and increasing 
margins. There is no significant difference in dose to organs 
at risk between the images modalities studied. Optimized 
planning in the average CT provides adequate coverage of 
GTV at different breathing phases. 
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Purpose or Objective: Stereotactic radiosurgery alone has 
become a popular treatment option in the management of 
patients with brain metastases. Multi- or single-isocenter 
dynamic conformal arcs (DCA) and volumetric modulated arc 
therapy (VMAT) are two common used delivery techniques. 
Recently, a dedicated inverse optimized brain metastases 
treatment planning solution using single isocenter multiple 
DCA (SIDCA) has been developed, with intend to carefully 
balance normal tissue protection, target coverage and 
treatment speed. The purpose of the current study was to 
investigate the feasibility of this novel software and to 
benchmark it against well-established multi-isocenter DCA 
and single isocenter VMAT approaches. 
 
Material and Methods: Ten previously treated patients were 
selected representing a variable number of lesions (1-8), 
range of target sizes and shapes most frequently observed in 
the practice of SRS for brain metastases. The original multi-
isocenter DCA (MIDCA) were replanned with both single-
isocenter VMAT approach and the novel brain metastases tool 
(Elements, Brainlab AG, Germany). The treatment dose was 
20 Gy at the 80% prescription isodose. For all the plans, the 
dose to the surrounding healthy brain tissue (brainstem, 
cochlea, optical nerve, eyes and lens) was optimized to 
minimize normal tissue complications. The plans were 
evaluated by calculation of Paddick conformity and gradient 
index, and the volume receiving 10 and 12 Gy indicating risk 
of radionecrosis. 
 
Results: All plans were judged clinically acceptable, but 
differences were observed in the dosimetric parameters. The 
mean conformity of the automated single-isocenter planning 
tool (SIDCA) compared similarly to the established MIDCA and 
VMAT treatment techniques (CISIDCA=0.65 ± 0.08, 
CIMIDCA=0.66 ±0.07 and CIVMAT=0.67 ±0.16). Comparable 
mean dose fall off was observed between SIDCA and MIDCA 
(GISIDCA =3.9 ± 1.4 and GIMIDCA=4.5 ± 1.6). On the other 
hand, the GI of the VMAT plans (GIVMAT=7.1 ± 3.1) were 
significantly higher compared to the SIDCA. The V10 and V12 
were significantly higher for VMAT plans (V10VMAT=67.9 
±55.9cc, V12VMAT=46.3 ±35.9cc) (p<0.05) compared to 
MIDCA (V10MIDCA=49.0 ±38.1cc, V12MIDCA=35.6 ±26.4cc) and 
SIDCA (V10=48.5 ± 35.9cc, V12=36.3 ± 27.1cc). 
 
Conclusion: The automated brain metastases treatment 
planning element, based on an inversely-optimized SIDCA 
approach, revealed comparable results to the general 
accepted MIDCA approach. By reducing the time on planning, 
patient and treatment setup, this software tool improves the 
planning and delivery efficiency while preserving the plan 
quality of the MIDCA technique and lowering low dose spread 
of the VMAT approach, suggesting that this novel software 
offers the best of both worlds (i.e. efficient single-isocenter 
DCA delivery). 
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Purpose or Objective: To examine the feasibility of 
flattening filter free (FFF) volumetric modulated arc therapy 
(VMAT) for extreme hypofractionation of prostate cancer and 
investigate the potential decrease in treatment time per 
fraction while preserving or improving the treatment quality. 
To investigate the impact of intrafractional prostatic 
displacement. 
 
Material and Methods: Single arc treatment plans with 
photon beam qualities 10 MV with flattening filter (FF), 6 MV 
FFF and 10 MV FFF were created for nine patients treated 
with conventional fractionation (78 Gy, 2 Gy/fraction) and 
hypofractionation (42.7 Gy, 6.1 Gy/fraction), respectively. 
Dose-volume histograms (DVH) for all beam qualities were 
statistically evaluated using a paired sample Student’s t-test. 
Treatment delivery was evaluated through measurements on 
a Varian TrueBeam™ using a Delta4 PT system (ScandiDos AB). 
The beam-on time for each plan was recorded. A motion 
study, including one FF and one FFF hypofractionated 
treatment plan, was also performed using the HexaMotion 
(ScandiDos AB) and with trajectory data from six authentic 
prostate movement patterns. 
 
Results: All treatment plans were approved by a senior 
radiation oncologist. Evaluating the DVHs, no significant 
differences between beam qualities or between fractionation 
schedules were observed. All objectives were met for all 
plans. At the treatment delivery all plans passed the gamma 
criterion 3%, 2 mm with a pass rate of 98.8% or higher. The 
beam-on time for all conventional treatment plans was 1.0 
minute. The mean beam-on time was 2.3 minutes for the 
hypofractionated 10 MV FF plan, 1.3 minutes for the 6 MV FFF 
and 1.0 minute for the 10 MV FFF. In the motion study, no or 
little effect was observed on the pass rate for displacements 
